stockholders, especially penny holders-possess a voracious

New Post Public Reply Private Reply Replies (1) Message Board
microcaps
486
stockholders, especially penny holders-possess a voracious hunger for info-

if pennies only announce what is already completed penny holders rarely are satisfied and would ask-"why didnt the company keep us informed?".
Holders WANT to know the companies plans and every step of those plans. Dammed if they do and dammed if they dont.
So at what point does the company issue updates etc.
At some point between an idea and completion.

Thats what NNLX did. They did dd /investigation re facilities etc and the costs of such etc and then made a plan to carry the product to completion. At that point NNLX informed us of those plans.

However, as I remember later, an unexpected falling pps- probably due to manipulation- the stock story of low pennies-the company either decided it would be punitive to pps to execute those particular plans at that time or it became impossible to do so.
NNLX,apparently aware of the destruction of many pennies via poisonous financing, has chosen to avoid spiraling financing. A clue to the clueless/pretending bashers- low pps penny companies have restricting finances- thats almost a given! That's a major reason for low pps! Besides many pennies don't even yet have a viable product nor the means to secure them-yet without even any equipment or viable way to obtain either many companies announce glorious plans not rooted in reality. NNLX is NOT in that category.

Navigating those financial restrictions can be and often is more difficult than dealing with the product. Bashers love it when companies fall prey to poisonous financing bc that means bashers will greatly profit-including apparently nano/pumpkin reportedly posting here under another alias after having been imo and that of others banned from this board- and often controlling the discussion,with every issue at best out of context, as they did w this issue.

NNLX, foiled by changing pps etc, which made it advisable not to use 1 or more of the expected financing methods,apparently went back to the financial drawing board,as growth in internal revenue alone would apparently be insufficient to meet their expected timelines.

Without poisonous financing w its high spiraling costs, the only direct way for a co to take advantage of being public (to counter the enormous headaches of being public) is to issue new shares,which can be dilutive or not, depending on what a company receives in return for those shares. Bashers seem to have convinced many penny traders that a company receives nothing in exchange for newly issued shares (as if ceo's were throwing shares out of the window on a drunken joyride). A company receives nothing when holders trade their existing shares.

Which should lead to the present narrative -which is ignored by bashers.
NNLX has been very careful re the issuance of new shares. So to avoid poisonous and dilutive etc financing, NNLX has recently introduced 2 new game changers to the financial drawing board:


1) Application to the NSF, via a professional grant writer, for grants which typically total ca 1.5 million for 3 stages

2) an even bolder move- taking concrete steps (see sept/oct? update) to sell patents in certain prescribed geographical areas for possible revenues of 35-50 million!!!!!!!!!!!!!!!!!!!!

Do the bashers, who bring up the issue of financing,as they did again,even remind readers of the RESULTING TRANSITION TO THE GRANT APPLICATION AND the road to PATENT SALES??? Of course not,that would be too intellectually honest and contextual !!!!!

Btw,advertising for patent sales does not restrict parties from pursuing other arrangements, like licensing. Such alternative arrangements can be subsumed under or be separate from patent sales,the patent sales terminology simply opening the doors for all kinds of discussions w other companies.

Very few companies at this pps would even have a patent, let alone the numerous country/regional patents NNLX has courtesy of their recent patent attorney (with a double medical doctorate) who spent years obtaining such numerous patents. Patent attorneys are, btw, especially outside of NYC or Wash D.C..,very rare. I've communicated w thousands of attorneys across the nation but never had the occasion to speak to a patent attorney-the only specialized attorney outside of the generalized reference of "attorney at law".




Nanologix Inc (NNLX) Stock Research Links

NNLX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 5

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 3

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 3

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading
Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 3

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 3

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 6

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding Your Rights as a Humacyte, Inc. Investor

Updated Category News Views 110

Understanding Your Rights as a Humacyte, Inc. Investor Humacyte, Inc. (NASDAQ: HUMA) has recently captured the attention of investors due to certain legal developments affecting its share value. If you are a shareholder who purchased shares during the specific class period of May 10, 2024, to October 17, 2024, you may want to take active steps to protect your investment...

Continue Reading
Jim Chanos Raises Concerns About Oracle's Accounting Issues

Updated Category News Views 552

Chanos Questions Oracle's Accounting Practices Notable short-seller Jim Chanos has recently highlighted some serious concerns regarding Oracle Corp's accounting integrity. He has voiced skepticism about the company's massive project backlog, especially a significant $300 billion deal partnered with OpenAI, emphasizing that its operational realization is years away and...

Continue Reading
Cyrus Biotechnology Advances Novel IgG Therapy with No Antibodies

Updated Category News Views 171

Promising Developments by Cyrus Biotechnology Cyrus Biotechnology, Inc. has unveiled groundbreaking data showcasing the effectiveness of its engineered IgG-degrading enzyme, CYR241, in a unique rabbit redosing model. This enzyme demonstrates significant therapeutic activity without the formation of anti-drug antibodies (ADAs) upon repeated administration. Understanding...

Continue Reading
GreenPower Motor Company: Strengthening Its Financial Future

Updated Category News Views 241

GreenPower Motor Company Secures New Term Loan Funding GreenPower Motor Company Inc. (NASDAQ: GP), an innovator in the production and distribution of all-electric medium and heavy-duty vehicles, recently completed the closing of the fifth tranche of its secured term loan offering. This strategic move aims to bolster its operational capabilities, particularly in the cargo,...

Continue Reading
Unlocking the Future: Insights into the Cloud Industry 2025

Updated Category News Views 226

The Promising Future of the Global Cloud Industry The global cloud industry is on a fast track to remarkable growth. Recent research indicates that the market is poised to expand from approximately USD 1,091.4 billion in one year to an impressive USD 1,256.8 billion by 2025. This represents a noteworthy year-over-year increase of about 15.1%. With such staggering figures,...

Continue Reading